Copy
View this email in your browser

ETW newsletter 15 December 2021

Thank you for all your amazing efforts during November European Testing Week to increase access to testing and raise awareness about the need for early testing for HIV, viral hepatitis and sexually transmitted infections. Thank you also to our sponsors, endorsers and supporters who help spread the ETW message throughout Europe. It was great to see so much activity on social media about all your ETW activities.  

How did your Testing Week go?

Please let us know more about how ETW went! As usual, we really hope you will take a few minutes to complete the online post-ETW evaluation survey.  This helps us to improve ETW; understand how the COVID-19 pandemic affects ETW; get knowledge on the different activities done across Europe and lastly get an insight into the impact of ETW which we can use for further planning and advocacy purposes.

Access the survey here: https://redcap.link/Nov2021ETWsurvey
 

The deadline is 7 January 2022.

If you have any questions, please feel free to email the ETW secretariat at eurotest.rigshospitalet@regionh.dk

The new European Test Finder has been launched - make sure your testing site is included!

How do I include my testing site?

  1. Create a profile for the testing site on https://www.testfinder.info/register
  2. Fill out the form to provide information about your testing services.

For easy instructions on what to do, watch this short video: https://www.youtube.com/watch?v=UbFVs1Ddq8M

What is the European Test Finder?

The European Test Finder (ETF) is a free online tool enabling users to search for their nearest testing site for HIV, viral hepatitis and other sexually transmitted infections in countries within the WHO European Region.

The previous ETF hosted by NAM Aidsmap has been discontinued, and all testing sites need to register on the new ETF website and submit information about their testing services.

For any questions, please send us an email: eurotestfinder.rigshospitalet@regionh.dk

Impact of COVID-19 on testing services

Take part in the 2021 EuroTEST assessment of the impact of COVID-19 on testing services for #HIV #HBV #HCV #STIs in the WHO European Region.  

Access the survey here: https://redcap.link/COVID-19_impact_2021
More info: https://www.eurotest.org/Projects-Collaborations/COVID-19-impact-assessment-on-testing

To understand the continued impact of the #COVID19 pandemic on testing services for HIV, viral hepatitis and STIs in the WHO European Region, the EuroTEST COVID-19 impact assessment consortium of partners invites you to participate in the 2021 survey. If you provide testing for one of these infections at the laboratory, clinical or community level, please consider responding to the survey.  

The survey is available in English and Russian, and deadline to complete is 21 January 2022.

Joint press release from European and International Testing Week


On the last day of #EuroTestWeek, Coalition Plus and EuroTEST launched a joint press release about the critical decline in testing for HIV, hepatitis and STIs, caused by the Covid-19 pandemic, and the importance of early testing and increased access to testing.
Read it here: https://bit.ly/3xyO1yJ

(Sponsored post)
Danish HCV FNA Point-of-Care testing program improves patient management and access to treatment.

Read more about this story here.
ETW Twitter page
ETW Facebook page
Website
If you no longer want to participate in ETW (both Spring and Autumn), please click the "Opt-out" link below and follow further instructions.

By choosing to "Opt-out" of European Testing Week, your organisation will:
- Be removed from our list of signed-up organisations;
- No longer receive the ETW newsletter, announcements or promotional offers with diagnostic kit companies.

Click here to Opt-Out of European Testing Week.